Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Nature plus nurture: the triggering of multiple sclerosis.
Understanding Drivers of Employment Changes in a Multiple Sclerosis Population.
Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.
SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β.
Moyamoya disease can masquerade as multiple sclerosis.
Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.
Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
Fingolimod affects gene expression profile associated with LPS-induced memory impairment.
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity.
Optic neuritis in a psoriatic arthritis patient treated by infliximab.
Comment on "matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis".
A TSPO ligand is protective in a mouse model of multiple sclerosis.
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
B lymphocytes in neuromyelitis optica.
BREMSO: a simple score to predict early the natural course of multiple sclerosis.
Reducing falls and improving mobility in multiple sclerosis.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer.
Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
Pages
« first
‹ previous
…
242
243
244
245
246
247
248
249
250
…
next ›
last »